The Global Novel Drug Delivery Systems in Cancer Therapy Industry is embarking on an unprecedented journey of growth, with a robust Compound Annual Growth Rate (CAGR) of 19.6% projected from 2022 to 2032. Future Market Insights (FMI), in its latest report, unveils a trajectory that propels the sector from US$ 14.8 billion in 2022 to …